NCT04174352
- Conditions
- ERα+ Breast Cancer, ESR1 Gene Mutation
- Locations
-
- University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States
- Wisconsin Oncology Network (WONIX) sites Madison, Wisconsin, United States
Clinical trial condition
ESR1 Gene Mutation
Explore clinical trials studying ESR1 Gene Mutation. Study availability and eligibility vary by location and protocol.
5 public trials
5 recruiting studies
ESR1 Gene Mutation trial results
Recruiting
PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
NCT07222215
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT06382948
- Conditions
- Advanced Breast Cancer, ER-positive Breast Cancer, ESR1 Gene Mutation, +1 more
- Locations
-
- Medizinische Universität Innsbruck Innsbruck, Austria
- Ordensklinikum Linz Barmherzige Schwestern Linz, Austria
- Ordination Priv.-Doz. Dr. Michael Hubalek Schwaz, Austria
- Medical University of Vienna Vienna, Austria
Recruiting
Current Status of Treatment for Chinese Patients With ESR1-mutated HR+/HER2-advanced Breast Cancer
NCT06548919
- Conditions
- Advanced Breast Cancer, ESR1 Gene Mutation
- Locations
-
- Tianjin Haidafu Internet Hospital Suzhou, Jiangsu, China
NCT06544577
- Conditions
- Advanced Breast Cancer, ESR1 Gene Mutation, Safety
- Locations
-
- Hainan Hospital of Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (Boao Research Hospital, Hainan) Qionghai, Hainan, China